Medical Device & Technology

Device can now be used in patients with symptomatic moderate-to-severe or severe mitral regurgitation who are not candidates for surgery or transcatheter edge-to-edge repair therapy.

Large NIH-funded studies show real-time alerts help doctors reduce unnecessary use of strong antibiotics

Experts say the lack of a consistent payment mechanism through Medicare has become a major roadblock to adoption.

RSP Systems achieves major milestone in non-invasive glucose monitoring technology

Oak Orchard Health taps AI tools from eClinicalWorks to boost efficiency, patient care

The impact of these tariffs on the global market has been significant. What's next for investors?

Cybersecurity attacks and ethical AI use emerge as critical concerns for physicians.

Association previously expressed grave concerns about the effect of tarrifs.

She replaces Tom Westrick, who is retiring after 20 years

Are your patients' medications about to get more expensive?

Trump's tariff announcements led to a stock market meltdown with trillions of dollars of losses from retirement accounts — at least on paper. What now? Here's what investors should consider.

Combined organization now serves more than 20 million members and 1,700 employers

Clearance is the first AI platform for real-time surgical measurements, marking major leap in operating room innovation

Groups say that tariffs could unfairly jeopardize patient care

American Heart Association says physicians should consider how digital drivers of health affect patients.

Predictmedix cites growing role in health and safety for its device’s success

The company also expects to submit its application for 510(k) clearance for its OneRF Trigeminal Nerve Ablation System in May, sooner than expected.

Swiss-based company’s plant will increase capacity to meet demand for autoinjectors

Between President Trump's tariff plan and sweeping layoffs at the FDA and HSS, the medical device industry is facing an uncertain future.

Under the terms, Boston Scientific will pay about $443 million upfront, plus up to $221 million if regulatory milestones occur.

Report shows industry hitting the $1.3 trillion mark by 2029

Omid Veiseh, PhD, faculty director of the Rice Biotech Launchpad, discusses his organization’s mission to create innovative biotechnology based on patient need.

‘The revolution begins today,’ new HHS Secretary RFK Jr. says.

Merged organizations pledge to advance innovative technologies to improve patient care.

Inovalon’s Safety Management solution now on PointClickCare Marketplace